Literature DB >> 7496837

Axillary node status in nonpalpable breast cancer.

K Dowlatshahi1, H C Snider, R Kim.   

Abstract

BACKGROUND: The metastatic status of the axillary nodes is prognostically important but its value has been questioned in the management of nonpalpable breast tumors. This study correlates the incidence of positive nodes with the size of the primary nonpalpable tumors.
METHODS: We retrospectively analyzed 220 invasive and 21 microinvasive breast cancers that were excised after needle localization and for which axillary dissections were subsequently performed. Of invasive cancers, 166 presented as mass lesions with or without microcalcifications and 54 as microcalcifications alone. The size of the mass lesions (n = 166) was determined mammographically and on pathologic specimens. They were subdivided into five groups according to diameter: (a) < or = 5 mm, (b) 6-10 mm, (c) 11-20 mm, (d) > 20 mm, and (e) unrecorded size.
RESULTS: Axillary metastases were found in 9% of patients whose cancer presented as microcalcifications alone. They were found in 0, 11, and 22% of patients in mammographic groups, a, b, and c, respectively. In the corresponding groups in which size was determined from the pathology report, metastases were found in 5, 10, and 27%.
CONCLUSION: The size of nonpalpable breast cancers measured on the excised gross specimen and by mammogram accurately predicts the likelihood of axillary node metastasis.

Entities:  

Mesh:

Year:  1995        PMID: 7496837     DOI: 10.1007/bf02306375

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  25 in total

1.  Needle-localized mammographic lesions. Results and evolving treatment strategy.

Authors:  H R Alexander; F C Candela; D D Dershaw; D W Kinne
Journal:  Arch Surg       Date:  1990-11

2.  A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma.

Authors:  P R Rosen; S Groshen; P E Saigo; D W Kinne; S Hellman
Journal:  J Clin Oncol       Date:  1989-03       Impact factor: 44.544

3.  The impact of microinvasion on axillary node metastases and survival in patients with intraductal breast cancer.

Authors:  J H Wong; K H Kopald; D L Morton
Journal:  Arch Surg       Date:  1990-10

4.  Axillary lymph node dissection for T1a breast carcinoma. Is it indicated?

Authors:  M J Silverstein; E D Gierson; J R Waisman; G M Senofsky; W J Colburn; P Gamagami
Journal:  Cancer       Date:  1994-02-01       Impact factor: 6.860

5.  Factors influencing prognosis in node-negative breast carcinoma: analysis of 767 T1N0M0/T2N0M0 patients with long-term follow-up.

Authors:  P P Rosen; S Groshen; D W Kinne; L Norton
Journal:  J Clin Oncol       Date:  1993-11       Impact factor: 44.544

6.  Nonpalpable breast lesions: findings of stereotaxic needle-core biopsy and fine-needle aspiration cytology.

Authors:  K Dowlatshahi; M L Yaremko; L F Kluskens; P M Jokich
Journal:  Radiology       Date:  1991-12       Impact factor: 11.105

Review 7.  Clinical decision-making in early breast cancer.

Authors:  C M Balch; S E Singletary; K I Bland
Journal:  Ann Surg       Date:  1993-03       Impact factor: 12.969

8.  New therapeutic possibilities in primary invasive breast cancer.

Authors:  B Cady; M D Stone; J Wayne
Journal:  Ann Surg       Date:  1993-09       Impact factor: 12.969

9.  Occult axillary lymph node metastases in invasive breast carcinoma: characteristics of the primary tumor and significance of the metastases.

Authors:  E J Wilkinson; L L Hause; R G Hoffman; J F Kuzma; D J Rothwell; W L Donegan; L J Clowry; U A Almagro; H Choi; A A Rimm
Journal:  Pathol Annu       Date:  1982

10.  Management of nonpalpable breast abnormalities.

Authors:  R E Symmonds; J W Roberts
Journal:  Ann Surg       Date:  1987-05       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.